Aryl hydrocarbon receptor and leptin promote prostate cancer progression and may be associated with chemoresistance.

被引：1
|
作者：
Khamit-Kush, Kofi K. [1 ]
Powell, Joann B. [1 ]
Handy, Jeffrey A. [2 ]
Bowen, Nathan J. [1 ]
Odero-Marah, Valerie [3 ]
Wu, Daqing [1 ]
机构：
[1] Clark Atlanta Univ, Atlanta, GA 30314 USA
[2] Morehouse Coll, Atlanta, GA USA
[3] Morgan State Univ, Baltimore, MD 21239 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2023年 / 32卷 / 01期
关键词：
D O I：
10.1158/1538-7755.DISP22-C023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C023
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [21] Decreasing ovarian cancer metastases and progression via restoration of microRNAs that target mediators of anoikis- and chemoresistance.
    Cittelly, Diana M.
    Cochrane, Dawn R.
    Howe, Erin N.
    Dimitrova, Irina
    Post, Miriam D.
    Russell, Broaddus R.
    Spillman, Monique A.
    Richer, Jennifer K.
    CANCER RESEARCH, 2013, 73
  • [22] Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1
    Lv, Ke-Jia
    Yu, Si-Zhe
    Wang, Yu
    Zhang, Shi-Rong
    Li, Wen-Yuan
    Hou, Jia
    Tan, De-Li
    Guo, Hui
    Hou, Yu-zhu
    CELLULAR SIGNALLING, 2024, 124
  • [23] Leptin contributes to prostate cancer progression.
    De Velasco, Marco A.
    Yamamoto, Yutaka
    Hatanaka, Yuji
    Kura, Yurie
    Ando, Naomi
    Fukushima, Emiko
    Nozawa, Masahiro
    Shimizu, Nobutaka
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2013, 73 (08)
  • [24] Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy - obstacles and perspectives
    Prochazkova, Jirina
    Kahounova, Zuzana
    Vondracek, Jan
    Soucek, Karel
    TRANSCRIPTION-AUSTIN, 2024,
  • [25] CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression
    Takayama, Ken-ichi
    Suzuki, Takashi
    Fujimura, Tetsuya
    Urano, Tomohiko
    Takahashi, Satoru
    Homma, Yukio
    Inoue, Satoshi
    CANCER RESEARCH, 2014, 74 (22) : 6542 - 6553
  • [26] Aryl hydrocarbon receptor nuclear translocator is associated with cisplatin resistance in cancer cells
    Chen, Ben-Kuen
    Kalpana, Sriram
    Chang, Wen-Chang
    CANCER RESEARCH, 2012, 72
  • [27] Leptin and leptin receptor expressions in prostate tumors may predict disease aggressiveness?
    Osorio, Clarice F.
    de Souza, Diogo B.
    Gallo, Carla B. M.
    Costa, Waldemar S.
    Sampaio, Francisco J. B.
    ACTA CIRURGICA BRASILEIRA, 2014, 29 : 44 - 48
  • [28] The aryl hydrocarbon receptor pathway and breast cancer
    Sakoff, Jennette
    Gilbert, Jayne
    Baker, Jennifer
    McCluskey, Adam
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 34 - 35
  • [29] The aryl hydrocarbon receptor as driver of cancer immunity
    Sherr, David
    Kenison-Whte, Jessica
    Wang, Zhongyan
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Cyclosporin may directly promote cancer progression
    Reactions Weekly, 1999, 741 (1) : 2 - 2
12345